Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography

被引:52
作者
Justesen, US
Pedersen, C
Klitgaard, NA
机构
[1] Univ So Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark
[3] Odense Univ Hosp, Dept Clin Biochem, DK-5000 Odense, Denmark
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 783卷 / 02期
关键词
indinavir; amprenavir; ritonavir; lopinavir; saquinavir; nelfinavir;
D O I
10.1016/S1570-0232(02)00728-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple HPLC method that quantitates all six currently available protease inhibitors and the nelfinavir active metabolite M8 in one assay is presented. A 500-mul plasma sample was treated by liquid-liquid extraction with a mixture of heptane and ethyl acetate. After evaporation, the residue was redissolved in sodium dihydrogenphosphate and acetonitrile and washed twice with heptane. Chromatography was performed with an analytical C-18 column. Ultraviolet detection at 210 and 239 nm was used. The present method is associated with high accuracy and low imprecision in the concentration range of 25-5000 ng/ml of all six protease inhibitors and M8. This makes it suitable for monitoring purposes. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:491 / 500
页数:10
相关论文
共 15 条
[1]  
AARNOUTSE R, 2001, 8 C RETR OPP INF, V734
[2]   Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients [J].
Baede-van Dijk, PA ;
Hugen, PWH ;
Verweij-van Wissen, CPWGM ;
Koopmans, PP ;
Burger, DM ;
Hekster, YA .
AIDS, 2001, 15 (08) :991-998
[3]  
Burger DM, 1998, ANTIVIR THER, V3, P215
[4]  
BURGER DM, 2001, 2 INT WORKSH CLIN PH
[5]  
Buttner J, 1979, Clin Chim Acta, V98, p145F
[6]   High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction [J].
Dailly, E ;
Thomas, L ;
Kergueris, MF ;
Jolliet, P ;
Bourin, M .
JOURNAL OF CHROMATOGRAPHY B, 2001, 758 (02) :129-135
[7]   The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring [J].
Gatti, G ;
Di Biagio, A ;
Casazza, R ;
De Pascalis, C ;
Bassetti, M ;
Cruciani, M ;
Vella, S ;
Bassetti, D .
AIDS, 1999, 13 (15) :2083-2089
[8]   Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography [J].
Hugen, PWH ;
Verweij-van Wissen, CPWGM ;
Burger, DM ;
Wuis, EW ;
Koopmans, PP ;
Hekster, YA .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :139-149
[9]   Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection [J].
Leibenguth, P ;
Le Guellec, C ;
Besnier, JM ;
Bastides, F ;
Macé, M ;
Gaudet, ML ;
Autret-Leca, E ;
Paintaud, G .
THERAPEUTIC DRUG MONITORING, 2001, 23 (06) :679-688
[10]   Standard methods to measure HIV drug concentrations [J].
Luber, AD ;
Merry, C .
LANCET, 2001, 358 (9285) :930-930